Prevention and management of neutropenic sepsis in patients with cancer: Summary of NICE guidance

BMJ (Online)

Volumn 345, Issue 7875, 2012, Pages

  Phillips, Robert ^a   Hancock, Barry ^b   Graham, John ^c   Bromham, Nathan ^d   Jin, Huajie ^c   Berendse, Sabine ^c  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c National Collaborating Centre for Cancer   (United Kingdom)

^d TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACUTE LEUKEMIA; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CANCER PATIENT; EMERGENCY CARE; HIGH RISK PATIENT; HUMAN; INFECTION RISK; LOW RISK POPULATION; MEDICAL EDUCATION; MEDICAL HISTORY; MEDICAL INFORMATION; NEUTROPENIA; NEUTROPENIC SEPSIS; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SEPSIS; SHORT SURVEY;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; GRANULOCYTE COLONY-STIMULATING FACTOR; GREAT BRITAIN; HUMANS; NEOPLASMS; NEUTROPENIA; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; SEPSIS; YOUNG ADULT;

EID: 84866627106     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e5368     Document Type: Short Survey

References (7)

1. Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 2006;106:2258-66.
2. National Confidential Enquiry into Patient Outcome and Death. Systemic anti-cancer therapy: for better, for worse? NCEPOD, 2008. www.ncepod.org.uk/ 2008sact.htm.
3. National Chemotherapy Advisory Group. Chemotherapy services in England: ensuring quality and safety. Department of Health, 2010. http://www.dh.gov.uk/ en/Publicationsandstatistics/Publications/DH-104500.
4. National Institute for Health and Clinical Excellence. Neutropenic sepsis: prevention and management of neutropenic sepsis in cancer patients. (Clinical guideline 151.) 2012. http://guidance.nice.org.uk/CG151.
5. National Cancer Action Team. Manual for cancer services: acute oncology - including metatastic spinal cord compression measures. 2011. www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-125727.
6. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000;18:3038-51.
7. Dommett R, Geary J, Freeman S, Hartley J, Sharland M, Davidson A, et al. Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting. Eur J Cancer 2009;45:2843-9.